Abstract:1887 Purposes: Reduced capacity to repair mutagen-induced DNA damage is implicated in susceptibility to cancer development. The nicotine-derived nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induced lung adenocarcinogen through formation of DNA adducts. Methods: We used the comet assay to assess whether susceptibility to NNK-induced DNA damage was associated with increased risk of lung cancer in a hospital-based case-control study. We measured baseline and NNK-induced DNA damage in peripheral blood lymphocyte assays from 401 previously untreated Caucasian lung cancer cases and 388 matched healthy controls. DNA damage using NNK as the mutagen challenge was visualized with the comet assay and quantified by the Olive tail moment parameter. Multivariable analysis was used to assess risks for lung cancer associated with level of DNA damage. Results: The baseline levels of DNA damage were statistically significantly higher in cases than in controls (tail moments: 1.22±0.57 vs. 1.14±0.50, P =0.025), as were NNK-induced DNA damage (2.42±1.15 vs. 2.16±1.07, P =0.001). The net NNK-induced DNA damage (NNK-induced subtracted by baseline) was also significantly higher in cases compared with controls (1.20 vs. 1.03, P = 0.018). When data were dichotomized at the median value of olive tail moments in the controls and adjusted for age, sex, and smoking status, higher levels of net NNK-induced DNA damage were associated with a significantly increased lung cancer risk (odds ratio [OR] = 1.45, 95% CI = 1.09 to 1.94). In addition, there was also a significant dose effect. Compared to individuals in the lowest quartile of damage, the ORs for individuals in the second, third and fourth quartiles were 1.32 (95% CI: 0.86-2.03), 1.59 (95% CI: 1.04-2.43), and 1.78 (95% CI: 1.17-2.70), respectively (P-for trend =0.005). In stratified analysis, the elevated risk appeared to be higher in adenocarcinoma (OR=1.50, 95% CI: 1.05-2.13) than in other histologies (OR=1.38, 95% CI, 0.95-2.00), and higher in heavy smokers (OR=1.64, 95% CI: 1.09-2.47) than in light smokers (OR=1.49, 95% CI, 0.79-2.79). Conclusions: This is the first study to use NNK as a challenge mutagen in the comet assay. The results suggest that NNK-induced DNA damage is associated with an increased risk of lung adenocarcinoma and the net NNK-induced olive tail moment measure may serve as a useful predictor of lung cancer risk. Supported by NCI grants CA 55769, CA 70907 and CA 86390.

Analysis of methyl DNA adducts and metabolites in BEAS-2B cells induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone

Proteomic Analysis of Different Temporal Expression Patterns Induced by N-Methyl-N′-nitro-N-nitrosoguanidine Treatment

Involvement of P53 Mutation and Mismatch Repair Proteins Dysregulation in NNK-Induced Malignant Transformation of Human Bronchial Epithelial Cells

Genotoxicity Study on Nicotine and Nicotine-Derived Nitrosamine by Accelerator Mass Spectrometry

NanoLC/ESI+ HRMS3 quantitation of DNA adducts induced by 1,3-butadiene

Enhancements of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism and carcinogenic risk via NNK/arsenic interaction

Nicotine Inhibits the Cytotoxicity and Genotoxicity of NNK Mediated by CYP2A13 in BEAS-2B Cells

NNK-induced DNA Damage As Measured by the Comet Assay is a Marker of Lung Cancer Risk

Hypermethylation of the ADIRF promoter regulates its expression level and is involved in NNK-induced malignant transformation of lung bronchial epithelial cells

Formamidopyrimidine adducts are detected using the comet assay in human cells treated with reactive metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)

Isotope Dilution nanoLC/ESI+-HRMS3 Quantitation of Urinary N7-(1-Hydroxy-3-buten-2-yl) Guanine Adducts in Humans and Their Use as Biomarkers of Exposure to 1,3-Butadiene

Metabolic study of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to the enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in vitro in human bronchial epithelial cells using chiral capillary electrophoresis

Cigarette Smoking, BPDE-DNA Adducts, and Aberrant Promoter Methylations of Tumor Suppressor Genes (TSGs) in NSCLC from Chinese Population

Metabolism-dependent mutagenicity of two structurally similar tobacco-specific nitrosamines ( N -nitrosonornicotine and N -nitrosoanabasine) in human cells, partially different CYPs being activating enzymes

Aberrant DNA Methylation in Radon And/or Cigarette Smoke-Induced Malignant Transformation in BEAS-2B Human Lung Cell Line

Characterization of Activation and Deactivation Pathways of 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK) in Rat Hepatocytes.

Upregulated DNMT3a coupling with inhibiting p62-dependent autophagy contributes to NNK tumorigenicity in human bronchial epithelial cells

NNK-induced DNA methyltransferase 1 in lung tumorigenesis in A/J mice and inhibitory effects of (-)-epigallocatechin-3-gallate.

4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Provokes Progression from Chronic Pancreatitis to Pancreatic Intraepithelial Neoplasia

[Induction of Pulmonary Precancerous Lesions by Tobacco-Specific NNK in Wistar Rats].

Malignant transformation of human bronchial epithelial cells with the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone